Komori
Softcreate Holdings Corp. (3371) · FactHigher research and development expenses

Research and Development Expenditure

First written in FY2017-Q1. 4 of 35 entries say "Restated". Latest entry: FY2026.

35entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2017-Q1 – FY20262016: 220162017: 420172018: 420182019: 420192020: 420202021: 420212022: 420222023: 320232024: 320242025: 220252026: 12026
Same theme, other companies
Continuation of Company-wide R&D Activities and Resource InvestmentA theme 204 companies write about · 0 as a headwind · 217 as a tailwind

90 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 186 companies compared. The sentences above are computed from all 186.Comparing 200 of the theme's 219 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026Higher research and development expensesAnnual report

    「As a result, total R&D expenses for the current consolidated fiscal year amounted to ¥70 million.」

    R&D expenses increased from ¥43 million in the previous fiscal year to ¥70 million.
  2. FY2026-H1Increase in R&D Expenses for the Interim PeriodAnnual report

    「The Group’s total R&D activities amounted to ¥27.564 million for the current interim consolidated accounting period.」

    R&D activity expenses increased from ¥13.955 million in the same period of the previous year to ¥27.564 million.
  3. FY2025Decline in R&D ExpensesAnnual report

    「As a result, total R&D expenses for the current consolidated fiscal year amounted to ¥43 million.」

    R&D expenses decreased from ¥83.856 million in the previous fiscal year to ¥43.666 million.
  4. FY2025-H1Decline in R&D ExpensesAnnual report

    「The Group’s total R&D activities amounted to ¥13.955 million for the current interim consolidated accounting period.」

    R&D activity expenses were disclosed at ¥13.955 million, down from ¥39.894 million for the cumulative period through the second quarter of the previous fiscal year.
  5. FY2024Decline in R&D ExpensesAnnual report

    「Total R&D expenses included in selling, general and administrative expenses and current-period manufacturing costs amounted to ¥83.856 million.」

    R&D expenses decreased from ¥147.999 million in the previous consolidated fiscal year to ¥83.856 million.
  6. FY2024-Q3Year-on-year increase in R&D expensesAnnual report

    「The Group’s total R&D activities amounted to ¥61.547 million for the cumulative consolidated period through the third quarter.」

    R&D activity expenses increased from ¥14.733 million in the same period of the previous year to ¥61.547 million.
  7. FY2024-Q2Year-on-year increase in R&D expensesAnnual report

    「The Group’s total R&D activities amounted to ¥39.894 million for the cumulative consolidated period through the second quarter.」

    R&D activity expenses increased from ¥9.976 million in the same period of the previous year to ¥39.894 million, and also increased from ¥25.051 million for the cumulative period through the first quarter.
  8. FY2024-Q1Year-on-year increase in R&D expensesAnnual report

    「The Group’s total R&D activities amounted to ¥25.051 million for the cumulative consolidated period through the first quarter.」

    R&D activity expenses increased from the ¥6.578 million recorded for the same period of the previous year to ¥25.051 million.
  9. FY2023-Q3R&D expenses down year on year, cumulative amount upAnnual report

    「The Group’s total R&D activities amounted to ¥14.733 million for the cumulative consolidated period through the third quarter.」

    R&D activity expenses increased from ¥9.976 million for the cumulative period through the second quarter to ¥14.733 million, but remained below the ¥76.649 million recorded in the same period of the previous year.
  10. FY2023-Q2Research and development expenses down year on yearAnnual report

    「The Group’s total R&D activities amounted to ¥9.976 million for the cumulative consolidated period through the second quarter.」

    R&D activity expenses decreased from ¥63.857 million in the same period of the previous year to ¥9.976 million.
  11. FY2023-Q1Research and development expenses down year on yearAnnual report

    「The Group’s total R&D activities amounted to ¥6.578 million for the cumulative consolidated period through the first quarter.」

    R&D activity expenses decreased from ¥25.056 million in the same period of the previous year to ¥6.578 million.
  12. FY2022Higher research and development expensesAnnual report

    「As a result, total research and development expenses for the current consolidated fiscal year were ¥84,854 thousand.」

    R&D expenses increased from ¥78.029 million in the previous period to ¥84.854 million. This comprised ¥51.192 million for the EC Solutions business and ¥33.661 million for the IT Solutions business.
  13. FY2022-Q3Year-on-year increase in R&D expensesAnnual report

    「The amount of research and development activity for the Group as a whole was ¥76,649 thousand during the third quarter of the current consolidated cumulative period.」

    Research and development activity increased from ¥57,873 thousand in the same period of the previous year to ¥76,649 thousand, also up from ¥63,857 thousand for the previous quarter cumulative period.
  14. FY2022-Q2Year-on-year increase in R&D expensesAnnual report

    「The amount of research and development activity for the Group as a whole was ¥63,857 thousand during the second quarter of the current consolidated cumulative period.」

    Research and development activity increased from ¥37,846 thousand in the same period of the previous year to ¥63,857 thousand, also up from ¥25,056 thousand for the first quarter cumulative period.
  15. FY2022-Q1Year-on-year increase in R&D expensesAnnual report

    「The amount of research and development activity for the Group as a whole was ¥25,056 thousand during the first quarter of the current consolidated cumulative period.」

    Research and development activity increased from ¥18,439 thousand in the same period of the previous year to ¥25,056 thousand.
  16. FY2021Higher research and development expensesAnnual report

    「As a result, total research and development expenses for the current consolidated fiscal year were ¥78,029 thousand.」

    Research and development expenses increased from ¥69,112 thousand in the previous fiscal year to ¥78,029 thousand. The breakdown was ¥56,524 thousand for the EC Solutions business and ¥21,505 thousand for the Systems Integration business.
  17. FY2021-Q3Higher research and development expensesAnnual report

    「The amount of research and development activity for the Group as a whole was ¥57,873 thousand during the third quarter of the current consolidated cumulative period.」

    Research and development activity increased from ¥37,846 thousand for the second quarter cumulative period to ¥57,873 thousand.
  18. FY2021-Q2Year-on-year increase in R&D expensesAnnual report

    「The amount of research and development activity for the Group as a whole was ¥37,846 thousand during the second quarter of the current consolidated cumulative period.」

    Research and development activity increased from ¥27,656 thousand in the same period of the previous year to ¥37,846 thousand.
  19. FY2021-Q1Year-on-year increase in R&D expensesAnnual report

    「The amount of research and development activity for the Group as a whole was ¥18,439 thousand during the first quarter of the current consolidated cumulative period.」

    Research and development activity increased from ¥17,002 thousand in the same period of the previous year to ¥18,439 thousand.
  20. FY2020Decline in R&D ExpensesAnnual report

    「As a result, total research and development expenses for the current consolidated fiscal year were ¥69,112 thousand.」

    Research and development expenses decreased from ¥83,967 thousand in the previous fiscal year to ¥69,112 thousand. The breakdown was ¥29,656 thousand for the EC Solutions business and ¥39,455 thousand for the Systems Integration business.
  21. FY2020-Q3Research and development expenses increased; down year on yearAnnual report

    「The amount of research and development activity for the Group as a whole was ¥42,377 thousand during the third quarter of the current consolidated cumulative period.」

    Expenditure on research and development activity increased from ¥27,656 thousand for the second quarter cumulative period to ¥42,377 thousand. However, it remained below the ¥51,831 thousand recorded in the same period of the previous year.
  22. FY2020-Q2Research and development expenses down year on yearAnnual report

    「The amount of research and development activity for the Group as a whole was ¥27,656 thousand during the second quarter of the current consolidated cumulative period.」

    Research and development activity amounted to ¥27,656 thousand for the second quarter cumulative period, below the ¥28,950 thousand recorded in the same period of the previous year.
  23. FY2020-Q1Higher research and development expensesAnnual report

    「The amount of research and development activity for the Group as a whole was ¥17,002 thousand during the first quarter of the current consolidated cumulative period.」

    Expenditure on research and development activity increased from ¥10,833 thousand in the same period of the previous year to ¥17,002 thousand.
  24. FY2019Higher research and development expensesAnnual report

    「As a result, total research and development expenses for the current consolidated fiscal year were ¥83,967 thousand.」

    Research and development expenses increased from ¥78,869 thousand in the previous fiscal year to ¥83,967 thousand. The breakdown was ¥31,307 thousand for the EC Solutions business and ¥52,659 thousand for the Systems Integration business.
  25. FY2019-Q3Higher research and development expensesAnnual report

    「The amount of research and development activity for the Group as a whole was ¥49,530 thousand during the third quarter of the current consolidated cumulative period.」

    Expenditure on research and development activity increased from ¥37,217 thousand in the previous quarter cumulative period to ¥49,530 thousand. However, it remained below the ¥51,831 thousand recorded in the same period of the previous year.
  26. FY2019-Q2Higher research and development expensesAnnual report

    「The amount of research and development activity for the Group as a whole was ¥37,217 thousand during the second quarter of the current consolidated cumulative period.」

    Expenditure on research and development activity increased from ¥28,950 thousand in the same period of the previous year to ¥37,217 thousand.
  27. FY2019-Q1Higher research and development expensesAnnual report

    「The amount of research and development activity for the Group as a whole was ¥10,833 thousand during the first quarter of the current consolidated cumulative period.」

    Expenditure on research and development activity increased from ¥8,168 thousand in the same period of the previous year to ¥10,833 thousand.
  28. FY2018Higher research and development expensesAnnual report

    「Total research and development expenses for the current consolidated fiscal year were ¥78,869 thousand.」

    Research and development expenses increased from ¥51,831 thousand for the third quarter cumulative period to ¥78,869 thousand for the full fiscal year.
  29. FY2018-Q3Higher research and development expensesAnnual report

    「The amount of research and development activity for the Group as a whole was ¥51,831 thousand during the third quarter of the current consolidated cumulative period.」

    Expenditure on research and development activity increased from ¥28,950 thousand for the second quarter cumulative period to ¥51,831 thousand.
  30. FY2018-Q2Higher research and development expensesAnnual report

    「The amount of research and development activity for the Group as a whole was ¥28,950 thousand during the second quarter of the current consolidated cumulative period.」

    Expenditure on research and development activity increased from ¥8,168 thousand for the first quarter cumulative period to ¥28,950 thousand.
  31. FY2018-Q1RestatedAnnual report

    「The amount of research and development activity for the Group as a whole was ¥8,168 thousand during the first quarter of the current consolidated cumulative period.」

    Expenditure on research and development activity for the Group as a whole continues to be disclosed.
  32. FY2017RestatedAnnual report

    「Total research and development expenses for the current consolidated fiscal year were ¥18,406 thousand.」

    Disclosure of research and development activities and expenditure aimed at improving the underlying technology of packaged software and software products continues.
  33. FY2017-Q3RestatedAnnual report

    「The amount of research and development activity for the Group as a whole was ¥12,002 thousand during the third quarter of the current consolidated cumulative period.」

    Expenditure on research and development activity for the Group as a whole continues to be disclosed.
  34. FY2017-Q2RestatedAnnual report

    「The amount of research and development activity for the Group as a whole was ¥11,763 thousand during the second quarter of the current consolidated cumulative period.」

    Expenditure on research and development activity for the Group as a whole continues to be disclosed.
  35. FY2017-Q1First statedAnnual report

    「The group's total research and development expenditure during the cumulative first quarter under review was ¥4,320 thousand.」

    The filing discloses the group's total R&D expenditure for the cumulative quarter.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Softcreate Holdings Corp.'s next results are scheduled for 2026-11-02. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Research and Development Expenditure | SOFTCREATE HOLDINGS CORP. (3371) | Komori